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Characterizing the malignancy and 
drug resistance of cancer cells from 
their membrane resealing response
T. H. Hui1,2, Z. L. Zhou1, H. W. Fong3, Roger K. C. Ngan3, T. Y. Lee3, Joseph S. K. Au3, 
A. H. W. Ngan1, Timothy T. C. Yip3 & Y. Lin1,2
In this report, we showed that two tumor cell characteristics, namely the malignancy and drug-
resistance status can be evaluated by their membrane resealing response. Specifically, membrane pores 
in a number of pairs of cancer and normal cell lines originated from nasopharynx, lung and intestine 
were introduced by nano-mechanical puncturing. Interestingly, such nanometer-sized holes in tumor 
cells can reseal ~2–3 times faster than those in the corresponding normal cells. Furthermore, the 
membrane resealing time in cancer cell lines exhibiting resistance to several leading chemotherapeutic 
drugs was also found to be substantially shorter than that in their drug-sensitive counterparts, 
demonstrating the potential of using this quantity as a novel marker for future cancer diagnosis and 
drug resistance detection. Finally, a simple model was proposed to explain the observed resealing 
dynamics of cells which suggested that the distinct response exhibited by normal, tumor and drug 
resistant cells is likely due to the different tension levels in their lipid membranes, a conclusion that is 
also supported by direct cortical tension measurement.
Currently, diagnosis of cancers largely relies on biopsy1,2, a method inevitably involving analyzing huge amount 
of biological information (like the wide spectrum of morphological features of cells) and then making, to certain 
extent, “subjective” interpretations which unfortunately can lead to incomplete or misleading differential diag-
nosis3. In addition, more accurate molecular classification of cancers, such as drug resistance identification, often 
requires long time colony culturing and screening4,5 (taking days or even weeks to complete) which may prevent 
the patients from receiving immediate treatment that could be crucial. As such, finding reliable and fast ways to 
differentiate cancer cells from normal ones, as well as among themselves, has always been an area of great interest. 
For example, significant progress has been made in recent years in utilizing different nanoparticles for cancer 
detection purposes6,7, although their cytotoxicity remains to be a concern8,9.
Interestingly, accumulating evidence has shown that the physical properties of cells are intimately related to 
their pathological state10–16. For instance, it was found that tumor cells are often softer than their normal coun-
terparts17 and their elastic moduli correlate with their metastatic potentials17–19. The rigidity of bacteria has also 
been reported to be significantly influenced by their drug resistance status20. However, measuring the stiffness of 
cells demands precise control over the position of the probe that deforms the cell and/or the force exerted by it, 
making it rather difficult to achieve a high throughput. In addition, it also appears to us that the uniqueness and 
robustness of using stiffness as a marker for cancer detection has not been rigorously established.
In this study, we used a mechanical puncturing approach (see Supplementary information A) to create 
nanometer-sized pores on the lipid bilayer in tumor and non-tumor cell lines from three different human organs, 
namely, nasopharynx, lung and intestine (culture protocols and cell lines are given in Supplementary information B), 
and then investigated their spontaneous resealing. Interestingly, it was found that the tumor status of the cells 
can be efficiently distinguished by how fast the membrane pores are resealed. Furthermore, we also showed that 
the resealing behavior of tumor cells exhibits a strong correlation with their anti-cancer drug resistance (refer to 
Supplementary Information C for details). Finally, through theoretical modeling and direct measurement, we 
demonstrated that the distinct resealing response observed here is likely due to the different tension levels in the 
lipid membrane of normal, drug-sensitive and drug-resistant cancer cells.
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Results
Spontaneous resealing of nano-sized membrane pores. Membrane pores in the nasopharyngeal 
carcinoma (NPC) cell line, HONE1 were created by a 500 nm -radius AFM indenter (Fig. 1A). Spontaneous 
resealing of the holes was monitored by taking snap shot images at a frame rate of 0.1 s−1 after removal of the 
indenter. Figure 1B shows that a membrane pore in HONE1 will typically disappear in ~20 seconds. To confirm 
whether the membrane was ruptured by the indenter, we have labeled the membrane fluorescently with lipid raft. 
As shown in the bottom panel of Fig. 1B, the lipid intensity in the punctured hole was essentially zero initially, 
manifested as a black region, demonstrating that the membrane is indeed ruptured. Interestingly, the resealing 
time for an immortalized normal nasopharyngeal cell line, NP69, was 250% longer (approximately 50 seconds, 
refer to Fig. 1C).
To examine whether such a huge difference is a general feature between cancer and normal cells, we systemati-
cally examined the resealing response in cell lines derived from three anatomical positions, namely, nasopharynx 
(NPC cell lines - HONE1, CNE2 and HK1 versus immortalized normal NP cell lines – NP69 & NP460), lung 
(lung cancer cell lines - A549 & NCI-H520 versus immortalized normal lung cell lines – HBE & 16HBEo-) and 
intestine (intestinal cancer cell line - Caco-2 versus intestinal normal cell line – FHs74Int). Interestingly, cancer 
cells were found to always reseal 200% to 300% times faster than the corresponding normal ones irrespective of 
the organs from which they were established (Fig. 2A).
More surprisingly, the resealing behavior of cancer cells also appears to be influenced by their drug-resistance 
status. Specifically, two pairs of cancer cell lines with and without resistance to Cisplatin (i.e. HONE1-EBV CisR & 
HK1-LMP1 CisR versus HONE1-EBV & HK1-LMP1 respectively), a drug widely used in treating head, neck and 
ovarian cancer patients, and one pair of NPC cell lines with and without resistance to AUY922, a drug targeting 
heat shock protein-90 (HSP90), were tested. All drug resistant cell lines exhibit a much shortened resealing time 
as compared to their non-resistant counterparts (Fig. 2B). Another commonly used drug in treating non-small 
cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) gene mutation is Erlotinib. 
Despite its efficacy, resistance can develop after prolonged usage of Erlotinib resulting in cancer relapse in many 
patients. To test whether the membrane resealing time is correlated with the resistance to Erlotinib, we performed 
the same membrane resealing experiments in nine different well-established lung cancer cell lines (HCC827, 
NCI-H3255, HCC2935, NCI-H358, NCI-H1650, A549, NCI-H23, NCI-H1975& NCI-H820). Indeed, our results 
Figure 1. Nanomechanical puncture test. (A) Schematics of the nano-mechanical puncturing test where a flat-
end cylindrical indenter is used (with actual images given in the inset) to penetrate and create a pore in the lipid 
bilayer membrane. (B) Representative optical (top) and lipid raft (bottom) images showing the resealing dynamics 
of a membrane pore in HONE1 cell. Amplified plots (after smoothing by a cstomized computer program in the 
optical case) are also given under the original ones. Note that, the black region in the lipid raft image has essentially 
zero lipid intensity indicating that the membrane was ruptured there. (C) Temporal evolution of the radii of 
membrane pores, normalized by the initial value 0.5 μ m (i.e. the radius of the indenter used), in HONE1 and 
NP69 cells. Error bar represents the standard deviation from 15 independent measurements for each cell type. A 
statistical confidence level of no less than 97% by t-test has been achieved in (C).
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showed that how fast membrane pores in these cells can reseal correlated well in a reversed stepwise fashion with 
their reported Erlotinib resistance21,22, refer to Fig. 2C.
Figure 2. Resealing time comparison among cell lines. (A) Comparison between the measured resealing time 
of 1 μ m membrane pores in different cancer and corresponding normal cell lines. (B) Bar plots of the resealing 
time of nasopharyngeal drug-resistant cell lines (HONE1-AUY R, HONE1-EBV Cis R and HK1-LMP1 Cis R) 
along with their parental cell lines (HONE1, HONE1-EBV, and HK1-LMP1) that are drug-sensitive.  
(C) Bar plots of the resealing time of lung cancer cells with different reported Erlotinib resistance (characterized 
by the critical Erlotinib concentration required to achieve 50% growth inhibition, i.e.IC50). (D) The resealing 
time of HONE1 cell line in different phases of AUY922 treatment cycles where the drug-resisting capability 
of cells is described by IC50 of AUY922, similar to that in (C). Asterisks here denote a statistically significant 
difference by t-test (* P < 0.05, * * P < 0.01, * * * P < 0.001) between paired samples and n stands for the number 
of independent trials. Results shown in (A–C) all have a statistical significance of P < 0.01 by one sample t-test 
while P < 0.05 in (D).
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Finally, to further confirm the reverse trend between the resealing time and drug-resistant characteristic, we 
developed a series of HONE1 sub-lines with gradual increase of resistance to AUY922 by pulsing HONE1 with 
the drug repeatedly for 6 months (Fig. 2D). Again, HONE1 subclones with increasing levels of AUY922 resistance 
exhibited a gradual decrease in the resealing time (Fig. 2D).
A theoretical model for pore resealing. To better understand the distinct resealing response observed 
here, recall that, from a thermodynamics point of view, the free energy of a membrane pore, with radius r, can be 
expressed as23,24
= piσ − γpiE r r r( ) 2 (1)2
where γ is the lipid bilayer tension while σ is the edge energy (or line tension) associated with the peripheral of the 
pore (Fig. 3A). Physically, σ originates from the fact that the hydrophobic tails of lipid molecules are exposed to 
water at the pore edge leading to an increase in the free energy. Once E is known, the size evolution of the pore can 
then be described by = −∂
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with r0 being the initial radius of the hole (i.e. the radius of the cylindrical probe used to puncture the cell wall). 
Given that the structure and diffusivity of lipid molecules in different cells are unlikely to vary significantly, the 
values of σ and D should be more or less the same across cell types (the adopted values of these two parameters, 
Figure 3. Puncture resealing model. (A) Schematic diagram illustrating the resealing of a membrane pore 
governed by its edge energy density σ and bi-layer tension γ. (B) Temporal evolution of the normalized pore 
radius. Experimental data are represented by markers while predictions from Eq. (2) are shown by lines where 
γ is chosen as 8 pN/μ m and 34.5 pN/μ m for tumor and normal cells, respectively. Other parameters adopted 
here are listed in Supplementary Information Table 2. (C) Resealing response of membrane holes with different 
initial diameters (1, 2 or 3 μ m). Markers here correspond to measurement data on A549 cells while lines 
represent predictions from Eq. (2) under a fixed γ of 8 pN/μ m. Experimental results shown in (B,C) were based 
on measurements on 15 live cells with P < 0.03 by one-sample t-test.
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compared favorably to those reported in the literature, are listed in Supplementary Table 2). As such, the key fac-
tor affecting the resealing dynamics concerned here is γ , noticing that r will decrease monotonically with respect 
to time as long as r0 < σ /γ according to Eq. (2).
Interestingly, within this theoretical framework, the observed big difference in the resealing time of tumor 
and normal cells can be well explained by assuming that the tension level in cancer cells is much lower than that 
in the corresponding normal ones. In particular, choosing γ = 8 pN/μ m, prediction from Eq. (2) matches well 
the observed size evolution of membrane pores, with an initial size of 500 nm in radius, in different cancerous 
cell lines such as HONE1, A549 and Caco-2. On the other hand, experimental data from normal cell lines such as 
NP69, HBE and FHs74Int can be well-fitted by Eq. (2) if the bilayer tension is taken to be 34.5 pN/μ m (Fig. 3B,C). 
We also compared predictions from Eq. (2) with observations regarding how membrane pores with different 
initial diameters (1, 2 or 3 μ m) evolve in A549 cell line. As shown in Fig. 3C, excellent agreement between theory 
and experiment has been achieved for a fixed γ at 8 pN/μ m.
To further confirm notion that the low resealing speed in normal cells, as compared to cancer ones, is caused 
by the high tension levels in their lipid membranes, we have conducted two sets of additional experiments. 
In the first one, the cortical tension (γ m) of cells was measured via nano-indentation (refer to Supplementary 
Information D). Indeed, it was found that this quantity in tumor cells is much lower than that in their normal 
counterparts (see Fig. 4A). Notice that the cortical tension is different from the lipid bilayer tension appeared in 
the resealing model described above. Actually, γ m (generated by the passive deformation of the actin cortex as well 
as the active contraction of myosin motors inside) is expected to be much larger than γ 25. Although we cannot 
measure the bilayer tension directly, it is reasonable to believe that a positive correlation between γ m and γ exists, 
that is a higher level of γ m will be accompanied by a higher level of γ and vice versa. Secondly, we monitored 
the resealing response of A549 cells treated with Jasplakinolide (Jas), Cytochalasin D (CytD) and Blebbistatin 
(Blebst). Jas and CytD are known to disrupt the actomyosin assembly in the cell cortex while the contractility of 
myosin will be inhibited by Blebst (see Supplementary Information E for details). As expected, a marked reduc-
tion in the resealing time, coupled with a decrease in the cortical tension, was observed in cells treated with Jas, 
CytD or Blebst (Fig. 4C,D). The resealing response of A549 cells undergoing hyperosmotic treatment was also 
examined (refer to Supplementary Information F). Basically, it was found that a higher increase in the medium 
osmolarity will lead to a larger shrinkage of cells as well as a faster resealing response (Supplementary Figure 4) 
which is consistent with our model predictions.
Lastly, to explore possible correlation between the stiffness and membrane resealing behavior of cells, the 
effective elastic moduli of different cancer (HONE1, A549 and Caco-2) and corresponding normal (i.e. NP69, 
Figure 4. Correlation between resealing time and cortical tension. (A) Measured cortical tension in different 
tumor and corresponding normal cells. (B) Effective elastic moduli of the cells listed in (A). (C) Measured 
cortical tension in Jas-, CytD- or Blebst-treated A549 cells. (D) Measured membrane resealing time in Jas-, 
CytD- or Blebst-treated A549 cells. Asterisks here have the same meanings as those defined in Fig. 2. Results 
shown here were based on measurements on 15 cells (in each case) and a statistical confidence level of no less 
than 95% by t-test has been achieved.
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HBE and FHS74Int) cell lines were measured by rate-jump indentation (see Supplementary Information G). As 
shown in Fig. 4B, tumor cells all appear to be softer than their normal counterparts, in agreement with previous 
studies17.
Discussion
In summary, here we demonstrated the potential of using membrane resealing time as a novel marker in differen-
tiating cancer cells from their normal counterparts. Specifically, it was shown that the membrane pores in various 
cancer cell lines derived from three anatomical positions, (namely, nasopharynx, lung and intestine) all reseal 
200% to 300% faster than those in the corresponding normal ones. More interestingly, we found that there is a 
strong correlation between the resealing response of tumor cells and their capability to resist anti-cancer drugs 
with a clearly shortened resealing time in different cancer cells with resistance against commonly used drugs 
including Cisplatin, AUY922 and Erlotinib. Given that current drug sensitivity tests, no matter by colony, dye 
exclusion assays or other biochemical means, often require days to even weeks to complete and the results gener-
ated are usually far from accurate enough for clinical decision making. Our approach may provide an alternative 
for achieving rapid drug-resistance identification in the future.
Our analysis and cortical tension measurement suggest that the distinct resealing response is likely due to 
the different tension levels in the lipid membrane of cells. Actually, previous studied have indeed found that 
several cancer (including leukemia and cervical carcinoma) cells have a lower cortical tension (or elasticity)11,26 
compared to their normal counterparts that possess a better differentiated cytoskeleton26. In addition, it has also 
been reported that the membrane can reseal faster in cells with a disrupted27 or rearranged28,29 (in the phase of 
mitosis) cytoskeletal structure, in consistent with our observations that cells treated with Jas, CytD, Blebst or 
hyperosmotic medium all exhibit a significantly reduced membrane resealing time. It is natural to postulate that 
the rapid resealing ability might provide a survival advantage for tumor cells by reducing the risk associated with 
membrane damages. If that is so, can we manipulate the tension level of cancer cells to make them more vulner-
able or reduce their drug resistance? Experiments will be planned to examine these questions by first looking 
at the phenomenon in a larger variety of cancer cell lines derived from other organs such as breast, ovary, liver, 
skin, prostate, kidney, gastric gland and brain. In addition, since techniques like electroporation30,31 and sonopo-
ration32,33 have all been well-established allowing us to create membrane holes in hundreds or thousands of cells 
simultaneously, it is conceivable that findings here could lead to high throughput cancer screening strategies in 
the future. Investigation along this line is underway.
Materials and Methods
Nano-mechanical puncturing. The cell puncturing experiments were conducted in a JPK NanoWizard® 
II AFM (JPK Instrumental). A probe with a flat ended silicon nitride tip (Microlevers, Veeco) of diameter of 1, 
2 or 3 μ m, and a cantilever spring constant of 0.035 N/m, was used. The AFM tip was first made to indent into 
the cell at a speed of 0.2 μ m/s until an indentation depth of 0.4 μ m was reached. This was followed by holding for 
30 s, and then retraction at a speed of 0.1 μ m/s. Size evolution of the hole in the plasma membrane was captured 
by time-lapse images, taken at a rate of 10 frames/sec, and then quantitatively analyzed by a MATLAB program 
(see Supplementary Information A and Supplementary Figure 1 for details). All tests were conducted at 25 °C and 
within 1 hour after the cells were removed from the incubator.
Cell lines and culturing protocols. The histology and source of all cell lines used in this study are provided 
in Supplementary Information B. Cells were maintained at 37 °C and 5% CO2humidified atmosphere. In addi-
tion, a total concentration of 2 × 105 cells/mL was incubated in confocal dishes without serum/growth factor for 
24 hours to achieve G0 phase synchronization prior to the actual test. Further details of the culturing protocols 
can be found in the Supplementary Information B.
Fluorescent staining of lipid by lipid raft. To visualize the membrane dynamics, we stained the lipid 
domains of HONE1 cells by lipid raft. The labeling was performed by using the Vybrant Alexa-Fluor-488 Lipid 
Raft labeling kit, following the manufacturer’s protocol (Invitrogen). Specifically, HONE1 cells were washed with 
ice-cold PBS three times and incubated with fluorescent CT-B. Then anti-CT-B antibody was added to crosslink 
the CT-B in the lipid rafts into patches readily to be visualized by fluorescence microscopy. Cells were kept at 
37 °C with 5% CO2 supply during the experiment.
Drugs and protocols for developing drug-resistance. Supply of HSP-90 inhibitor drug, AUY922 was 
obtained from Novartis Pharmaceuticals (HK) Ltd. The NPC sub-line (HONE1-AUY922-R) which is resist-
ant to AUY922 was established by pulsing HONE1 cell line with 30 nM AUY922 repeatedly every two to three 
days for six months until drug resistance is developed. The cisplatin-resistant cell lines (HK1-LMP1 CisR and 
HONE1-EBV CisR) were provided by Professor Brigette Ma & Dr. Eric Wong from the Department of Clinical 
Oncology, Chinese University of Hong Kong. The whole series of lung cancer cell lines with and without resist-
ance to the anti-EGFR targeted drug, Erlotinib were acquired from ATCC. For other details of cell lines and drug 
resistance nature, please refer to Supplementary Information B and C.
Cortical tension measurement. The same protocol used in the mechanical puncture tests, without the 
retraction stage at the end, was adopted here. In particular, the contact force between the cell and the cylindrical 
probe during the indenting and subsequent holding stages was recorded which, in conjunction with a simple 
model, enabled the so-called cortical tension of cells to be estimated (refer to Supplementary Information D for 
details). In our experiments, each cell was indented five times at different locations.
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